Compare Heron Therapeutics Inc (HRTX) vs Rio Tinto (ADR) (RIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Rio Tinto (ADR) — how do they compare? Heron Therapeutics Inc trades at $0.41 (market cap $68.01M), while Rio Tinto (ADR) trades at $94.47 (market cap $150.89B). The key difference: Rio Tinto (ADR) is far larger — about 2218.6× Heron Therapeutics Inc's market cap, and Rio Tinto (ADR) pays a 4.98% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Rio Tinto (ADR) for 10 Days on average.
| HRTX | RIO | |
|---|---|---|
Market Cap | $68.01M | $150.89B |
Volume | 1,891,941 | 1,492,444 |
Sector | Health | Basic Materials |
52-Week High | $1.49 | $112.04 |
52-Week Low | $0.27 | $65.44 |
Typical Hold Time | 35 Days | 10 Days |
Enterprise Value | $174.75M | $164.24B |
Dividend Yield | — | 4.98% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) trades at $0.39, up 0.95% with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings discussions.
The outlook remains challenged by persistent losses and negative margins, though strong analyst support suggests potential upside. Key risks include execution on sales targets and achieving profitability. The stock's low price near 52-week lows presents speculative opportunity but requires careful risk management given financial performance.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Rio Tinto (ADR)
Rio Tinto is a global mining company that produces metals and minerals including iron ore, aluminium, copper, and lithium. Its operations supply materials used in construction, manufacturing, transportation, and energy systems.
Read more on RIO →
